Cleared Traditional

K770804 - RESP. SYNCYTIAL-FA LABELLHD (8-301-RF)

K770804 is an FDA 510(k) clearance for RESP. SYNCYTIAL-FA LABELLHD (8-301-RF), manufactured by Flow Laboratories, Inc.. The device is a Class 1 Immunology device with product code GQG cleared through the Traditional 510(k) pathway after a 17-day FDA review.

K770804 · Flow Laboratories, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1977
Decision
17d
Days
Class 1
Risk

K770804 is an FDA 510(k) clearance for the RESP. SYNCYTIAL-FA LABELLHD (8-301-RF). Classified as Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus (product code GQG), Class I - General Controls.

Submitted by Flow Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on May 20, 1977 after a review of 17 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.3480 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Flow Laboratories, Inc. devices

FDA 510(k) Submission Details - K770804

510(k) Number K770804 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 1977
Decision Date May 20, 1977
Days to Decision 17 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 105d · This submission: 17d
Pathway characteristics
Predicate-based equivalence.

GQG Device Classification - Class 1, General Controls

Product Code GQG Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3480
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GQG Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus

All 27
Devices cleared under the same product code (GQG) and FDA review panel - the closest regulatory comparables to K770804.
IMAGEN RESPIRATORY SYNCYTIAL VIRUS TEST
K854081 · Boots-Celltech Diagnostics, Inc. · Jan 1986
RESPIRATORY SYNCYTIAL VIRUS ID REAGENT
K853695 · Viromed Laboratories, Inc. · Dec 1985
RESPIRATORY SYNCYTIAL VIRUS ANTIGEN &
K802936 · Orion Diagnostica, Inc. · Dec 1980
RESP. SYNCYTIAL-FA LABELLED PRESERUM
K770808 · Flow Laboratories, Inc. · May 1977